In pregnancy: effect of iron and folic acid on riboflavin status.
D000747:Anemia, Hypochromic / Q000097:blood* / Q000188:drug therapy; D001769:Blood; D004357:Drug Synergism; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000378:metabolism; D005492:Folic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007501:Iron / Q000494:pharmacology* / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D009747:Nutritional Physiological Phenomena; D010922:Placenta Diseases / Q000097:blood; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood*; D012256:Riboflavin / Q000097:blood* / Q000494:pharmacology / Q000627:therapeutic use; D014470:Umbilical Cord
D005492:Folic Acid; D007501:Iron; D012256:Riboflavin